David Wilson
Senior Director and Global Head of Oncology Chemis
Oncology
AstraZeneca
Ireland
Biography
Heading up a team of over 100 research chemists across the UK and US, David has more than 19 years’ experience in the pharmaceutical industry as a medicinal chemist, working across multiple therapy areas includinAn expert in epigenetics and lead author of the seminal Nature paper “A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response”, David has a particular research interest in exploring this growing area of science for oncology in AstraZeneca. Passionate about people development, David’s role as Head of Department is focused on giving individuals the right balance of support and space to foster an environment that enables creativity and great science to flourish.g neurodegeneration, immuno-inflammation, infectious diseases and oncology.
Research Interest
His many research interests include protein kinases, epigenetics, structure-based drug design, CNS-focused drug discovery and phenotypic screening.
